Open Access

Table 3

Extracted data from the included trials.

Author Year (ref.) Measured outcomes Placebo
Curcumin
unit Method of measure Data presented as:
before after before after
Abbase et al. 20 1 724 Serum TAC 50.7 ± 45 47.63 ± 25.27 37.06 ± 12.66 40.31 ± 13.24 ng/ml Elisa Mean ± SD
Alizadeh et al. 20 1 725 Serum MDA 1.05 ± 0.1 1.08 ± 0.1 0.96 ± 0.09 0.73 ± 0.07 μmol/l TBARS method Mean ± SD
TAC 1.36 ± 0.08 1.35 ± 0.09 1.24 ± 0.07 1.95 ± 0.05 μmol/l Colorimetry Mean ± SD
DiSilvestro CAT 28 ± 4 27 ± 4 29 ± 2 50 ± 7 nmol/ml kit Mean ± SD
et al. 201226 Plasma SOD 4658 ± 405 4748 ± 458 4798±401 4807 ± 445 U/ml Spectrophotometry Mean ± SD
GPx 14.6 ± 6.3 15.4 ± 6.2 ELISA Mean ± SD
Hejazi et al. 20 1 627 Plasma TAC 9.1 ± 2.3 10.6 ± 1.3 10.7 ± 2.0 12.8 ± 2.1 U/mL Assay kit Mean ± SD
SOD 195.2 ± 43.1 215.2 ± 83.5 226.1 ± 143.1 189.4 ± 115.4 U/L Mean ± SD
CAT 134.4 ± 62.7 134.8± 60.2 139.7 ± 110.2 111.2 ± 80.9 U/L Mean ± SD
GPx 125.9 ± 17.1 126.8± 12.0 123.4 ± 15.4 125.6 ± 13.4 U/mL Mean ± SD
Jimenez- Osorio et al. 20 1 628 Plasma Diabetic MDA 3.66 ± 0.42 2.59 ± 0.26 3.44 ± 0.37 2.83 ± 0.24 nM Spectrophotometry Mean ± SE
GSH 3.49 ± 0.37 3.029 ± 0.24 2.70 ± 0.24 3.05 ± 0.24 nM Mean ± SE
GR 0.107 ± 0.009 3.127± 0.01 0.116 ± 0.01 0.108 ± 0.008 U/mL Mean ± SE
GPX 0.20 ± 0.01 0.20 ± 0.01 0.22 ± 0.01 0.18 ± 0.02 U/mL Mean ± SE
Jimenez- Osorio et al. 20 1 628 Plasma Non-diabetic MDA 3.07 ± 0.39 3.05 ± 0.31 4.06 ± 0.37 2.94 ± 0.22 nM Spectrophotometry Mean ± SE
GSH 2.56 ± 0.28 3.03 ± 0.15 3.84 ± 0.42 3.71 ± 0.33 nM Mean ± SE
GR 0.11 ± 0.008 0.118 ± 0.01 0.118 ± 0.007 0.126 ± 0.01 U/mL Mean ± SE
GPX 0.22 ± 0.01 0.23 ± 0.04 0.23 ± 0.01 0.28 ± 0.06 U/mL Mean ± SE
Judaki et al. 201718 Gastric mucosa MDA 2.63 ± 0.42 2.92 ± 0.24 2.47 ± 0.33 2.33 ± 0.70 μmol/L Mean ± SD
TAC 2.52 ± 0.37 2.50 ± 0.60 2.04 ± 0.47 1.94 ± 0.32 μmol/L Mean ± SD
Nasseri et al. 20 1 729 Serum MDA 38.70 ± 12.24 39.90 ± 12.37 41.03 ± 14.96 37.12 ± 11.70 μmol/L Colorimetric assay Mean ± SD
TAC 191.46 ± 76.16 196.10 ± 72.57 187.09 ± 82.26 207.96 ± 91.72 μmol/L Mean ± SD
CAT 6.20 ± 3.73 6.01 ± 3.87 5.68 ± 3.95 5.81 ± 3.76 μ/mL Mean ± SD
Pakfetrat et al. 201519 Plasma MDA 8.6 ± 1.4 7.5 ± 1.1 7.5 ± 2.5 6.0 ± 2.4 nmol/mL Colorimetric Mean ± SD
Panahi et al. 201230 Serum SOD 58.01 ± 12.17 57.01 ± 8.84 57.68 ± 12.67 65.85 ± 13.84 μKat/l kits Mean ± SD
GPX 57.34 ± 9.67 56.34 ± 11.67 63.68 ± 9.34 74.68± 21.34 μKat/l Mean ± SD
CAT 663.47 ± 66.35 656.63 ± 54.51 647.80 ± 87.68 832.33 ± 154.53 μKat/l Mean ± SD
Panahi et al. 2014 a31 Serum GSH 8.91 ± 1.86 11.33 ± 4.32 10.90 ± 2.77 21.02 ± 4.24 μg/mL Spectrophotometry Mean ± SD
MDA 24.38 ± 3.21 22.47 ± 4.92 25.38 ± 3.61 11.84 ± 3.51 nmol/mL Mean ± SD
Panahi et al. 2014 b32 Serum SOD 0.70 ± 0.19 0.80 ± 0.24 0.75 ± 0.33 2.43 ± 0.62 U/mL Spectrophotometry Mean ± SD
CAT 10.21 ± 1.76 9.57 ± 1.71 14.08 ± 3.13 27.93 ± 4.49 U/mL Mean ± SD
GSH 8.85 ± 1.87 11.74 ± 4.25 10.69 ± 3.08 20.96 ± 3.40 μg/mL Mean ± SD
MDA 24.38 ± 3.18 25.44 ± 4.75 25.53 ± 3.75 20.23 ± 21.32 nmole/mL Mean ± SD
Panahi et al. 2015 a33 Serum SOD 1.70 ± 0.41 1.98 ± 0.29 1.47 ± 0.31 2.41 ± 0.37 U/mL Spectrophotometry Mean ± SD
MDA 19.56 ± 2.73 20.16 ± 3.11 19.38 ± 3.08 15.62 ± 2.59 nmole/mL Mean ± SD
Panahi et al. 2015 b34 Serum SOD 4.13 ± 0.36 3.76 ± 0.44 4.02 ± 0.29 6.94 ± 0.91 U/mL Spectrophotometry Mean ± SE
GSH 3.43 ± 0.22 3.41 ± 0.43 3.67 ± 0.19 5.06 ± 0.62 μg/mL Mean ± SE
MDA 23.11 ± 0.40 20.62 ± 0.99 23.00 ± 0.55 17.73 ± 1.19 nmol/mL Mean ± SE
Panahi et al. 20 1 620 Serum TAC 3.17 (2.42-3.80) 2.63 (2.24-3.20) 3.17 (2.65-3.89) 3.84 (2.43-4.30) nmol/mg Colorimetry Median (IQR)
SOD 3.39 ± 1.01 2.96 ± 0.78 3.46 ± 0.99 3.86 ± 0.76 U/mL Spectrophotometry mean ± SD
MDA 3.74 ± 1.32 3.88 ± 0.98 3.90 ± 1.06 3.05 ± 0.91 nmol/mL mean ± SD
Roohi et al. 201735 Plasma TAC 207.21 ± 14.41 190.09 ± 13.51 190.99 ± 12.61 322.52 ± 21.62 μmol/L Spectrophotometer Mean ± SE
GSH 1.36 ± 0.05 1.51 ± 0.10 1.26 ± 0.029 1.90 ± 0.17 μmol/L Mean ± SE
MDA 0.96 ± 0.04 0.97 ± 0.01 0.99 ± 0.026 0.97 ± 0.005 μmol/L TBARS method Mean ± SE
Srivastava et al. 201636 Serum MDA 5.15 ± 0.14 4.91 ± 0.11 5.03 ± 0.16 3.69 ± 0.12 nmol/ml TBARS method Mean ± SE
Sudheeran et al. 201621 (Standard curcumin) Plasma SOD 0 0 0 0 U/mL Mean ± SD
GPx 25.97 ± 3.29 28.60 ± 2.96 33.04 ± 2.17 39.13 ± 1.30 U/mL Mean ± SD
Sudheeran et al. 20 1 621 (Formulated curcumin) Plasma SOD 0 0 0 0 U/mL Mean ± SD
GPx 25.97 ± 3.29 28.60 ± 2.96 41.85 ± 4.36 67.57 ± 2.61 U/mL Mean ± SD

Superoxide dismutase (SOD); Total antioxidant capacity (TAC); Malondialdehyde (MDA); Reduced glutathione (GSH); Catalase (CAT); Glutathione reductase (GR); Glutathione peroxidase (GPX); Glutathione (GSH); Thiobarbituric acid-reactive substances (TBARS); Gas chromatography mass spectrometry (GC-MS)

Note: Data of one article was emailed by author. (DiSilvestro et al. 2012)

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.